ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lance Neill Joins Elixir as New Chief Operating Officer

Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD) that provides pharmacy benefits and services, today announced that veteran healthcare and pharmacy executive Lance Neill has joined the company as chief operating officer. Neill was most recently vice president of network development and contracting for Centene’s portfolio of managed care products, representing $32 billion in annual pharmacy spend. Prior to that, he served in multiple senior leadership roles with major healthcare brands including Diplomat Pharmacy and Walmart Stores, Inc.

Lance brings substantial experience in pharmacy network development and contracting, specialty pharmacy, finance, analytics and operational oversight. At Elixir, he will oversee the core operational functions, including Elixir Insurance. He will also be responsible for Elixir’s strategy development, ensuring that the company remains positioned for continued innovation and growth.

“Elixir’s opportunities have never been more compelling,” said Neill. "It is clear that regional health plans and mid-market employers are looking for a more surefooted approach to managing pharmacy spend and driving better health outcomes. And it is clear that as part of the Rite Aid enterprise, Elixir offers significant differentiation in target markets. I am excited to join a purpose-driven company, that is committed to helping people achieve whole health for life."

“Elixir is a critical component of Rite Aid’s growth strategy, and we are doubling-down on our investment to position the company as a market leader. Lance is a seasoned and trusted industry executive who consistently delivers results,” said Heyward Donigan, president and chief executive officer, Rite Aid. “He is uniquely qualified to drive strategic prioritization and accountability within Elixir, with a laser focus on operational excellence. In the months to come, I will work closely with Lance and the rest of the Elixir executive team to continue our march forward."

About Rite Aid Corporation

Rite Aid Corporation is on the front lines of delivering healthcare services and retail products to Americans 365 days a year. Our pharmacists are uniquely positioned to engage with customers and improve their health outcomes. We provide an array of whole being health products and services for the entire family through over 2,500 retail pharmacy locations across 17 states. Through Elixir, we provide pharmacy benefits and services to millions of members nationwide. For more information, www.riteaid.com.

About Elixir

Elixir, a fully owned subsidiary of Rite Aid Corporation, is a pharmacy services provider offering pharmacy benefit management, Medicare-approved prescription drug plans, mail and specialty pharmacy solutions, and prescription discount programs. With the unique ability to optimize the full pharmacy care experience, Elixir is crafting solutions for today’s pharmacy benefits challenges and helping people achieve whole health for life. For more information, visit www.elixirsolutions.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.10
+0.00 (0.00%)
AAPL  275.25
+0.00 (0.00%)
AMD  237.52
+0.00 (0.00%)
BAC  53.63
+0.00 (0.00%)
GOOG  291.74
+0.00 (0.00%)
META  627.08
+0.00 (0.00%)
MSFT  508.68
+0.00 (0.00%)
NVDA  193.16
+0.00 (0.00%)
ORCL  236.15
+0.00 (0.00%)
TSLA  439.62
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.